In a new study, researchers suggest a drug used to treat multiple sclerosis may combat physical disabilities associated with the neurological disease. Multiple sclerosis is an unpredictable disease that affects a victim's central nervous system by disrupting the flow of information between the body and the brain. The cause of the disease remains unknown. According to UPI, in a study published in the journal Neurology, researchers from the American Academy of Neurology tested the effectiveness of the drug alemtuzumab in restoring physical capabilities lost in patients with relapsing-remitting MS, the most common form of multiple sclerosis. Bibiana Bielekova explained that the results are encouraging, but exactly how alemtuzumab may reverse damage is yet to be investigated."